Gene · 5300
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances of Osterix Transcription Factor in Osteoblast Differentiation and Bone Formation. | Front Cell Dev Biol | 2020 | 33384998 | PubTator, text mining | PubMed |
| The Role of Hypoxia-Inducible Factor Post-Translational Modifications in Regulating Its Localisation, Stability, and Activity. | Int J Mol Sci | 2020 | 33383924 | PubTator, text mining | PubMed |
| Analysis of interleukin-1 receptor associated kinase-3 (IRAK3) function in modulating expression of inflammatory markers in cell culture models: A systematic review and meta-analysis. | PLoS One | 2020 | 33382782 | PubTator, text mining | PubMed |
| Voltage-Gated Potassium Channels as Regulators of Cell Death. | Front Cell Dev Biol | 2020 | 33381507 | PubTator, text mining | PubMed |
| Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF-β/Smad signaling to drive breast cancer progression. | Clin Transl Med | 2020 | 33377651 | PubTator, text mining | PubMed |
| All Roads Lead to Auxin: Post-translational Regulation of Auxin Transport by Multiple Hormonal Pathways. | Plant Commun | 2020 | 33367243 | PubTator, text mining | PubMed |
| The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives. | Front Oncol | 2020 | 33364199 | PubTator, text mining | PubMed |
| In silico derived small molecules targeting the finger-finger interaction between the histone lysine methyltransferase NSD1 and Nizp1 repressor. | Comput Struct Biotechnol J | 2020 | 33363704 | PubTator, text mining | PubMed |
| Differentiation of Trafficking Pathways at Golgi Entry Core Compartments and Post-Golgi Subdomains. | Front Plant Sci | 2020 | 33363561 | PubTator, text mining | PubMed |
| Editorial: Role of Neutrophils in Inflammatory Diseases. | Front Immunol | 2020 | 33363549 | PubTator, text mining | PubMed |
| Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer. | Front Pharmacol | 2020 | 33362547 | PubTator, text mining | PubMed |
| MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies. | Int J Mol Sci | 2020 | 33348804 | PubTator, text mining | PubMed |
| MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. | Oncoimmunology | 2020 | 33344042 | PubTator, text mining | PubMed |
| Plant cell divisions: variations from the shortest symmetric path. | Biochem Soc Trans | 2020 | 33336690 | PubTator, text mining | PubMed |
| Editorial: Phosphorylation-Dependent Peptidyl-Prolyl Cis/Trans Isomerase PIN1. | Front Cell Dev Biol | 2020 | 33330517 | PubTator, text mining | PubMed |
| Alterations in Tau Metabolism in ALS and ALS-FTSD. | Front Neurol | 2020 | 33329356 | PubTator, text mining | PubMed |
| Extracellular Vesicles Loaded miRNAs as Potential Modulators Shared Between Glioblastoma, and Parkinson's and Alzheimer's Diseases. | Front Cell Neurosci | 2020 | 33328891 | PubTator, text mining | PubMed |
| The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics. | Int J Mol Sci | 2020 | 33322239 | PubTator, text mining | PubMed |
| Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications. | Cells | 2020 | 33316954 | PubTator, text mining | PubMed |
| MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. | J Hematol Oncol | 2020 | 33308268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5300/papers?page=58